Human Leukocyte Antigens and Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma: Old Associations Offer New Clues into the Role of Immunity in Infection-Associated Cancers
Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV) associated tumor. In addition to EBV, host genetic factors are believed to be important determinants of NPC risk. Of all genes studies to date, human leukocyte antigen (HLA) genes have shown the most consistent evidence for association...
Main Authors: | Wen-Hui eSu, Allan eHildesheim, Yu-Sun eChang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00299/full |
Similar Items
-
Novel Therapies Boosting T Cell Immunity in Epstein Barr Virus-Associated Nasopharyngeal Carcinoma
by: Sarah Renaud, et al.
Published: (2020-06-01) -
Molecular Detection of Epstein - Barr virus in Nasopharyngeal Carcinoma among Sudanese population
by: Ali Edris, et al.
Published: (2016-11-01) -
Epstein-Barr DNA in advanced pediatric nasopharyngeal cancer
by: Marlinda Adham, et al.
Published: (2021-09-01) -
Epstein-Barr Virus Mediated Signaling in Nasopharyngeal Carcinoma Carcinogenesis
by: Timmy Richardo, et al.
Published: (2020-08-01) -
Lack of association between cigarette smoking and Epstein Barr virus reactivation in the nasopharynx in people with elevated EBV IgA antibody titres
by: Yufeng Chen, et al.
Published: (2018-02-01)